[go: up one dir, main page]

IN2014MN02433A - - Google Patents

Info

Publication number
IN2014MN02433A
IN2014MN02433A IN2433MUN2014A IN2014MN02433A IN 2014MN02433 A IN2014MN02433 A IN 2014MN02433A IN 2433MUN2014 A IN2433MUN2014 A IN 2433MUN2014A IN 2014MN02433 A IN2014MN02433 A IN 2014MN02433A
Authority
IN
India
Prior art keywords
formula
compound
derivatives
relates
mtcc
Prior art date
Application number
Inventor
Prabhu Dutt Mishra
Sreekumar Sankaranarayanan Eyyammadichiyil
Saji David George
Shailendra Sonawane
Narayan Subhash Chakor
Abhijit Roychowdhury
Rajiv Sharma
Original Assignee
Piramal Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Entpr Ltd filed Critical Piramal Entpr Ltd
Publication of IN2014MN02433A publication Critical patent/IN2014MN02433A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15Depsipeptides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

This invention relates to an isolated compound of Formula (1) or derivatives or pharmaceutically acceptable salts thereof. The invention also includes all isomeric and tautomeric forms of the compound of Formula (1) or the derivatives thereof. The present invention further relates to processes for the production of the compound of Formula (1) by fermentation of the fungal strain of Actinomycetes (PM0895172/MTCC 684) pharmaceutical compositions comprising the compound of Formula (1) as the active ingredient; and use of the said compounds or composition containing them in the treatment of cancer.
IN2433MUN2014 2012-05-07 2013-05-06 IN2014MN02433A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261643814P 2012-05-07 2012-05-07
PCT/IB2013/053613 WO2013168075A1 (en) 2012-05-07 2013-05-06 Hexadepsipeptide analogues as anticancer compounds

Publications (1)

Publication Number Publication Date
IN2014MN02433A true IN2014MN02433A (en) 2015-08-21

Family

ID=49550252

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2433MUN2014 IN2014MN02433A (en) 2012-05-07 2013-05-06

Country Status (15)

Country Link
US (2) US9475842B2 (en)
EP (1) EP2847212A4 (en)
JP (1) JP2015517485A (en)
KR (1) KR20150008173A (en)
CN (1) CN104603147A (en)
AR (1) AR090959A1 (en)
AU (1) AU2013257609A1 (en)
BR (1) BR112014027843A2 (en)
CA (1) CA2872813A1 (en)
IL (1) IL235600A0 (en)
IN (1) IN2014MN02433A (en)
MX (1) MX2014013498A (en)
NZ (1) NZ702684A (en)
RU (1) RU2014149097A (en)
WO (1) WO2013168075A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102389725B1 (en) * 2020-02-14 2022-04-25 서울대학교산학협력단 Cyclic peptide compound containing piperazic acid, a preparing method thereof, and a use thereof
US20240140992A1 (en) * 2021-02-22 2024-05-02 Lodo Therapeutics Corporation Hexadepsipeptide compounds and methods of using the same
WO2023081764A1 (en) * 2021-11-05 2023-05-11 Zymergen Inc. Hexadepsipeptide compounds and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3148851B2 (en) * 1994-10-25 2001-03-26 積水化学工業株式会社 New antitumor agent
US5858971A (en) * 1994-10-25 1999-01-12 Sekisui Chemical Co., Ltd. Cyclic peptide and method of making same by culturing a strain of actinomyces S. nobilis
JPH11269090A (en) * 1998-03-24 1999-10-05 Sekisui Chem Co Ltd Medical material
US8076287B2 (en) * 2006-03-29 2011-12-13 Thallion Pharmaceuticals Inc. Cyclic hexadepsipeptides, processes for their production and their use as pharmaceuticals

Also Published As

Publication number Publication date
US9475842B2 (en) 2016-10-25
WO2013168075A1 (en) 2013-11-14
US20160354430A1 (en) 2016-12-08
MX2014013498A (en) 2015-11-13
EP2847212A1 (en) 2015-03-18
CN104603147A (en) 2015-05-06
AU2013257609A1 (en) 2014-12-18
US20150080312A1 (en) 2015-03-19
CA2872813A1 (en) 2013-11-14
JP2015517485A (en) 2015-06-22
NZ702684A (en) 2016-08-26
AR090959A1 (en) 2014-12-17
IL235600A0 (en) 2015-01-29
KR20150008173A (en) 2015-01-21
EP2847212A4 (en) 2015-12-30
BR112014027843A2 (en) 2017-06-27
RU2014149097A (en) 2016-06-27

Similar Documents

Publication Publication Date Title
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
MX2015017861A (en) Benzothiophene derivatives as estrogen receptor inhibitors.
IN2014MN02106A (en)
PH12013501704A1 (en) Substituted aminobutyric derivatives as neprilysin inhibitors
TW201240990A (en) Antiviral compounds
GEP20146125B (en) Aminopyrimidines as syk inhibitors
MY165087A (en) Neprilysin inhibitors
GEP20156285B (en) Compounds and compositions as trk inhibitors
GEP201706671B (en) Heterocyclyl compounds as mek inhibitors
IN2014CN04530A (en)
IN2014MN02598A (en)
JO3781B1 (en) Quinolone derivatives
PH12013500301A1 (en) Oxadiazole inhibitors of leukotriene production
MY199730A (en) Piperidine-substituted mnk inhibitors and methods related thereto
JO3115B1 (en) Pyridazinone Compounds and Their Use as DAAO Inhibitors
PH12016500885A1 (en) Novel heterocyclic compounds
IN2015DN01119A (en)
EA201291217A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVES 1- (β-D-GLUKOPIRANOSIL) -2-THIENYLMETYLBENZENE AS NZGT INHIBITORS
TN2015000574A1 (en) Compounds and compositions as inhibitors of mek
PH12016501977A1 (en) 2-AMINO-6-METHYL-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]THIAZIN-8a(8H)-YL-1,3-THIAZOL-4-YL AMIDES
UA103329C2 (en) Normal;heading 1;heading 2;heading 3;SALTS OF HIV INHIBITOR COMPOUNDS
MX370598B (en) Novel annelated phenoxyacetamides.
MX2017008074A (en) IMIDAZOPYRIDAZINE DERIVATIVES AS PI3Kß INHIBITORS.
MD20160111A2 (en) Cycloalkyl-linked diheterocycle derivatives